253 related articles for article (PubMed ID: 22938516)
21. Intravitreal low-dosage bevacizumab for retinopathy of prematurity.
Harder BC; von Baltz S; Jonas JB; Schlichtenbrede FC
Acta Ophthalmol; 2014 Sep; 92(6):577-81. PubMed ID: 24020921
[TBL] [Abstract][Full Text] [Related]
22. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
Flavahan PW; Lavy TE; Wykes W
Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
[TBL] [Abstract][Full Text] [Related]
24. [Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity].
Alba LE; Zaldua RA; Masini RA
Arch Soc Esp Oftalmol; 2015 Feb; 90(2):81-6. PubMed ID: 25459682
[TBL] [Abstract][Full Text] [Related]
25. Successful Surgical Management of Retinopathy of Prematurity Showing Rapid Progression despite Extensive Retinal Photocoagulation.
Gadkari SS; Kulkarni SR; Kamdar RR; Deshpande M
Middle East Afr J Ophthalmol; 2015; 22(3):393-5. PubMed ID: 26180484
[TBL] [Abstract][Full Text] [Related]
26. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7.
Chhablani J; Rani PK; Balakrishnan D; Jalali S
Semin Ophthalmol; 2014 Jul; 29(4):222-5. PubMed ID: 24117452
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacological treatment for retinopathy of prematurity].
Stahl A; Agostini H; Jandeck C; Lagrèze W
Ophthalmologe; 2011 Aug; 108(8):777-85; quiz 786-7. PubMed ID: 21853221
[TBL] [Abstract][Full Text] [Related]
28. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.
Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
J AAPOS; 2014 Apr; 18(2):120-3. PubMed ID: 24698606
[TBL] [Abstract][Full Text] [Related]
29. Spectral-domain optical coherence tomography of the macula in preterm infants treated with bevacizumab for retinopathy of prematurity.
Dorta P; Kychenthal A
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):321-6. PubMed ID: 25856817
[TBL] [Abstract][Full Text] [Related]
30. [VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM; Helbig H
Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249
[TBL] [Abstract][Full Text] [Related]
31. Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.
Park SW; Jung HH; Heo H
Acta Ophthalmol; 2014 Dec; 92(8):810-3. PubMed ID: 24909062
[No Abstract] [Full Text] [Related]
32. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
[TBL] [Abstract][Full Text] [Related]
33. Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up.
Martínez-Castellanos MA; Schwartz S; Hernández-Rojas ML; Kon-Jara VA; García-Aguirre G; Guerrero-Naranjo JL; Chan RV; Quiroz-Mercado H
Retina; 2013 Feb; 33(2):329-38. PubMed ID: 23099498
[TBL] [Abstract][Full Text] [Related]
34. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P; Kychenthal A
Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
[TBL] [Abstract][Full Text] [Related]
35. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
Lalwani GA; Berrocal AM; Murray TG; Buch M; Cardone S; Hess D; Johnson RA; Puliafito CA
Retina; 2008 Mar; 28(3 Suppl):S13-8. PubMed ID: 18317338
[TBL] [Abstract][Full Text] [Related]
36. What is the optimal dosage for intravitreal bevacizumab for retinopathy of prematurity?
Spandau U
Acta Ophthalmol; 2013 Mar; 91(2):e154. PubMed ID: 22989079
[No Abstract] [Full Text] [Related]
37. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
Eldweik L; Mantagos IS
Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.
Hartnett ME
Clin Perinatol; 2014 Dec; 41(4):925-43. PubMed ID: 25459781
[TBL] [Abstract][Full Text] [Related]
39. Management of retinopathy of prematurity.
Fleck BW
Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F454-6. PubMed ID: 23813885
[TBL] [Abstract][Full Text] [Related]
40. [Retinopathy of prematurity - therapy. Part 2].
Prepiaková Z; Tomčíková D; Kostolná B; Gerinec A
Cesk Slov Oftalmol; 2014 Apr; 70(2):50-4. PubMed ID: 25030312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
